Currently, there is no effective treatment for extrapulmonary LAM.[12–14] We herein present 2 cases of extrapulmonary pelvic LAM which were successfully treated with everolimus (Afinitor—Novartis Pharmaceuticals), an mTOR inhibitor. The gene discussed is MTOR; the disease is lymphangioleiomyomatosis.